2014-09406. Novus International, Incorporated; Filing of Food Additive Petition (Animal Use)  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice of petition.

    SUMMARY:

    The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by Novus International, Inc., proposing that the food additive regulations be amended to provide for the safe use of ethoxyquin in rendered fats and oils used in animal feed.

    DATES:

    Submit either electronic or written comments on the petitioner's environmental assessment by May 27, 2014.

    ADDRESSES:

    Submit electronic comments to: http://www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Isabel W. Pocurull, Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-453-6853.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Under the Federal Food, Drug, and Cosmetic Act (section 409(b)(5) (21 U.S.C. 348(b)(5)), we are giving notice that we have filed a food additive petition (FAP 2283) submitted by Novus International, Inc., 20 Research Park Dr., Saint Charles, MO 63304. The petition proposes to amend the food additive regulations in part 573 Food Additives Permitted in Feed and Drinking Water of Animals (21 CFR part 573) to provide for the safe use of ethoxyquin in rendered fats and oils used in animal feed.

    We are reviewing the potential environmental impact of this petition. To encourage public participation consistent with regulations issued under the National Environmental Policy Act (40 CFR 1501.4(b)), we are placing the environmental assessment submitted with the petition that is the subject of this notice on public display at the Division of Dockets Management (see DATES and ADDRESSES) for public review and comment.

    Interested persons may submit either electronic comments regarding this document to http://www.regulations.gov or written comments to the Division of Dockets Management (see ADDRESSES). It is only necessary to send one set of comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. We will post comments we receive to the docket at http://www.regulations.gov. We will also place on public display, in the Division of Dockets Management and at http://www.regulations.gov, any amendments to, or comments on, the petitioner's environmental assessment without further announcement in the Federal Register. If, based on our review, we find that an environmental impact statement is not required, and this petition results in a regulation, we will publish the notice of availability of our finding of no significant impact and the evidence supporting that finding with the regulation in the Federal Register in accordance with 21 CFR 25.51(b).

    Start Signature

    Dated: April 22, 2014.

    Bernadette Dunham,

    Director, Center for Veterinary Medicine.

    End Signature End Supplemental Information

    [FR Doc. 2014-09406 Filed 4-24-14; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Published:
04/25/2014
Department:
Food and Drug Administration
Entry Type:
Proposed Rule
Action:
Notice of petition.
Document Number:
2014-09406
Dates:
Submit either electronic or written comments on the petitioner's environmental assessment by May 27, 2014.
Pages:
22910-22910 (1 pages)
Docket Numbers:
Docket No. FDA-2014-F-0452
PDF File:
2014-09406.pdf
CFR: (1)
21 CFR 573